Radiopharmaceutical administration equipment

Abstract

To provide a radiopharmaceutical administration facility that can reduce or eliminate movement of an object person after administering a radiopharmaceutical.SOLUTION: A radiopharmaceutical administration facility 100 comprises a treatment and waiting room 104 in which a radiopharmaceutical is administered to a subject 50 and the subject 50 waits for a predetermined time after administration of the radiopharmaceutical. In the treatment and waiting room 104, a radiopharmaceutical can be administered to the subject 50. Thereafter, the subject 50 can wait for a predetermined time in the treatment and waiting room 104 that is the same room, without moving to another room. In the radiopharmaceutical administration facility according to a comparative example, administration was performed in a treatment room 105 for about 5 minutes, and the subject 50 moved to a standby recovery room 109 and waited for about 50 minutes. On the other hand, in the treatment and waiting room 104, administration and waiting can be performed in the same room.SELECTED DRAWING: Figure 2

Description

[Technical Field]

[0001] The present invention relates to radiopharmaceutical administration equipment. [Background technology]

[0002] A conventional technique in this field is a radiopharmaceutical administration facility described in Patent Document 1. This radiopharmaceutical administration facility includes a treatment room for administering a radiopharmaceutical to a subject, and a waiting room in which the subject waits for a predetermined period of time after administration. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] Japanese Patent Application Laid-Open No. 2006-200256 Summary of the Invention [Problem to be solved by the invention]

[0004] In the radiopharmaceutical administration facility described above, a treatment room for administering the radiopharmaceutical to the subject and a waiting room for the subject to wait for a predetermined period of time after administration are separate rooms. Therefore, after the subject is administered the radiopharmaceutical in the treatment room, he or she moves to the separate room to wait. There has been a demand for minimizing or eliminating such movement of the subject after administration.

[0005] In view of the above problems, an object of the present invention is to provide a radiopharmaceutical administration facility that can reduce or eliminate the need for a subject to move after administration of a radiopharmaceutical. [Means for solving the problem]

[0006] The radiopharmaceutical administration equipment of the present invention is a radiopharmaceutical administration equipment that administers a radiopharmaceutical to a subject, and includes a treatment waiting room in which the radiopharmaceutical is administered to the subject and the subject waits for a predetermined period of time after the administration of the radiopharmaceutical.

[0007] The radiopharmaceutical administration equipment of the present invention includes a treatment waiting room in which a radiopharmaceutical is administered to a subject and the subject waits for a predetermined period of time after the administration of the radiopharmaceutical. In the treatment waiting room, the radiopharmaceutical can be administered to the subject. After that, the subject can wait for a predetermined period of time in the same treatment waiting room without having to move to another room. As a result, the need for the subject to move after the administration of the radiopharmaceutical can be reduced or eliminated.

[0008] The treatment waiting room may have a plurality of administration units for administering and a plurality of waiting units for waiting, and each waiting unit may correspond to a corresponding administration unit. The administration units and waiting units that correspond to each other may be located close to each other or at the same location. In this case, a subject who has been administered a radiopharmaceutical at a certain administration unit may wait by moving a short distance to the corresponding waiting unit, or without moving at all.

[0009] The treatment waiting room may include a plurality of installation units for placing subjects, and the administration unit and the waiting unit may be configured as the same installation unit. In this case, the subjects who have been administered the radiopharmaceutical in the administration unit may wait there without moving.

[0010] The treatment waiting room may include a plurality of installation sections for installing subjects, and radiation-shielding shielding walls may be installed between the installation sections. In this case, when a radiopharmaceutical is being administered to a subject installed in a certain installation section, the shielding walls can block radiation from reaching a subject installed in an adjacent installation section.

[0011] The shielding wall may have a through-hole through which a tube for transporting a radiopharmaceutical passes. In this case, when administering a radiopharmaceutical to a subject from an administration device, the administration device can be placed on the opposite side of the shielding wall, and the radiopharmaceutical can be administered to the subject through the tube that passes through the through-hole in the shielding wall. In this case, an operator operating the administration device can administer the radiopharmaceutical to the subject through the shielding wall.

[0012] The radiopharmaceutical administration equipment may further include an administration equipment room provided next to the treatment waiting room and housing administration equipment for supplying a radiopharmaceutical, and the administration equipment room may supply the radiopharmaceutical to the administration unit in the treatment waiting room that performs administration via a transport flow path. In this case, the radiopharmaceutical can be supplied from the administration equipment room to the subject at each administration unit via the transport flow path. Therefore, the radiopharmaceutical can be administered to the subject at each administration unit without the subject having to move.

[0013] The transport channel from the administration equipment room may be extended to the administration part through a groove or a penetration provided in at least one selected from the wall, floor, and ceiling separating each room. In this case, the wall can extend the transport channel to the administration part while shielding the transport channel from radiation that transports the radiopharmaceutical.

[0014] The radiopharmaceutical administration equipment may further include a mobile administration device for administering the radiopharmaceutical to the subjects. In this case, the administration device is movable and can be moved close to each subject. Therefore, the radiopharmaceutical can be administered to the subjects at each administration unit without the subjects having to move.

[0015] The treatment waiting room has a plurality of administration units for administering the drug, and the floor between the administration units does not need to have any steps. In this case, the administration device can move smoothly on the floor to approach each administration unit. [Effects of the Invention]

[0016] According to the present invention, it is possible to provide radiopharmaceutical administration equipment that can reduce or eliminate the need for a subject to move after administration of a radiopharmaceutical. [Brief explanation of the drawings]

[0017] [Figure 1] 1 is a conceptual plan view showing the overall configuration of a radiopharmaceutical administration facility according to an embodiment of the present invention. [Figure 2] FIG. 2 is a conceptual plan view showing the configuration of a treatment waiting room of the radiopharmaceutical administration facility shown in FIG. [Figure 3]FIG. 10 is a conceptual plan view showing the configuration of a treatment waiting room of a radiopharmaceutical administration facility according to a modified example. [Figure 4] FIG. 2 is a schematic cross-sectional view showing the structure around the transport channel in the wall portion. [Figure 5] FIG. 10 is a conceptual plan view showing the configuration of a treatment waiting room of a radiopharmaceutical administration facility according to a modified example. [Figure 6] FIG. 10 is a conceptual plan view showing the configuration of a treatment waiting room of a radiopharmaceutical administration facility according to a modified example. [Figure 7] FIG. 10 is a conceptual plan view showing a shielding wall of a radiopharmaceutical administration facility according to a modified example. DETAILED DESCRIPTION OF THE INVENTION

[0018] Hereinafter, an embodiment of the present invention will be described with reference to the drawings.

[0019] The radiopharmaceutical administration equipment 100 is equipment for administering a radiopharmaceutical to a subject (subject) undergoing a PET (positron emission tomography) examination. FIG. 1(a) is a schematic diagram showing the configuration of the first floor of the radiopharmaceutical administration equipment 100. FIG. 1(b) is a schematic diagram showing the configuration of the second floor of the radiopharmaceutical administration equipment 100. As shown in FIG. 1(a), the radiopharmaceutical administration equipment 100 has a reception desk 101 and a changing room 102 on the first floor. The reception desk 101 is an area where subjects are checked in and paid for. The changing room 102 is an area where subjects can change clothes after checking in. As shown in FIG. 1(b), the radiopharmaceutical administration equipment 100 has an examination room 103, a treatment waiting room 104, a toilet 106, an examination room 107, and a waiting and recovery room 108 on the second floor. The examination room 103 is an area where subjects are interviewed after changing clothes. The treatment waiting room 104 is an area where a radiopharmaceutical is administered to a subject after the medical interview has been completed, and where the subject waits for a predetermined period of time after the administration of the radiopharmaceutical. Assuming that the administration takes approximately 5 minutes in the treatment waiting room 104, approximately 50 minutes of waiting time is ensured after the administration. The toilet 106 is an area where the subject urinates after the administration of the radiopharmaceutical. The examination room 107 is an area where the subject is examined with a PET camera after the administration of the radiopharmaceutical. The waiting and recovery room 108 is an area where the subject waits and rests after the examination with the PET camera.

[0020] Next, with reference to FIG. 2, the detailed configuration of treatment waiting room 104 will be described. Note that in the following description, XY coordinates may be used. The X-axis direction is a predetermined direction parallel to the horizontal direction, and the Y-axis direction is a direction parallel to the horizontal direction and perpendicular to the X-axis direction. Treatment waiting room 104 is a space in radiopharmaceutical administration equipment 100, partitioned by walls 110, 111, 112, and 113 that separate the space from other rooms or corridors. Walls 110, 111, 112, and 113 are made of a radiation-shielding material, such as concrete. Wall 110 and wall 111 face each other in parallel and spaced apart in the Y-axis direction. Wall 110 is located on the positive side of the Y-axis direction. Wall 112 and wall 113 face each other in parallel and spaced apart in the X-axis direction. Wall 113 is located on the positive side of the X-axis direction. A doorway 114 is formed in the wall 110 for entering and exiting the treatment waiting room 104. Subjects and workers (nurses) can enter and exit between a space 115 such as another room or a corridor and the treatment waiting room 104. The doorway 114 may be provided with an openable and closable door.

[0021] The treatment waiting room 104 has an administration unit 2 that administers a radiopharmaceutical to the subject 50, and a waiting unit 3 that waits. The treatment waiting room 104 is a room in which movement from the administration unit 2 to the waiting unit 3 is confined within the same room, or movement from the administration unit 2 to the waiting unit 3 is eliminated. "Within the same room" means that they are within the same space partitioned by the walls of the radiopharmaceutical administration equipment 100. In this embodiment, the administration unit 2 and the waiting unit 3 are configured by the same installation unit 6. The installation unit 6 is configured by a bed on which the subject 50 is placed.

[0022] The treatment waiting room 104 has a plurality of administration units 2, i.e., installation units 6, that perform administration. In the example shown in FIG. 2, the treatment waiting room 104 has installation units 6A and 6B that are aligned along a wall 112 in the negative region of the room in the X-axis direction, and installation units 6C, 6D, and 6E that are aligned along a wall 113 in the positive region of the room in the X-axis direction. Installation units 6A and 6B are arranged from the negative side to the positive side of the Y-axis direction. Installation units 6C, 6D, and 6E are arranged from the positive side to the negative side of the Y-axis direction. The orientation of installation units 6A, 6B, 6C, 6D, and 6E is not particularly limited, but in this embodiment, they are arranged so that the X-axis direction is their longitudinal direction. The floor surface 104a between each installation unit 6 (administration unit 2) does not have any steps. That is, installation units 6A, 6B, 6C, 6D, and 6E are arranged on the same continuous, flat floor surface 104a.

[0023] Shielding walls 7 that block radiation are provided between each of the installation sections 6. The shielding walls 7 are members that further divide the same room. The shielding walls 7 are thinner than the walls 110, 111, 112, and 113 that serve as structures that separate the rooms themselves. The lower end of the shielding wall 7 is installed on the floor surface 104a, but the upper end may or may not reach the ceiling.

[0024] Specifically, a shielding wall 7A is provided between the installation portion 6A and the installation portion 6B. The shielding wall 7A extends from the wall portion 112 toward the positive side in the X-axis direction. The positive end of the shielding wall 7A in the X-axis direction extends further toward the positive side in the X-axis direction than the positive ends of the installation portions 6A and 6B in the X-axis direction. A shielding wall 7B is provided between the installation portion 6C and the installation portion 6D. A shielding wall 7C is provided between the installation portion 6D and the installation portion 6E. The shielding walls 7B and 7C extend toward the negative side in the X-axis direction from the wall portion 113. The negative ends of the shielding walls 7B and 7C in the X-axis direction extend further toward the negative side in the X-axis direction than the negative ends of the installation portions 6C, 6D, and 6E in the X-axis direction. In addition, a shielding wall 7D extending from the wall portion 111 toward the positive side in the Y-axis direction is provided between the installation portions 6A and 6B and the installation portions 6C, 6D, and 6E. Between the shielding wall 7A and the shielding wall 7D, a gap large enough to allow the administration device 10 described below to pass through is formed. Between the shielding wall 7D and the wall portion 110, a gap large enough to allow the administration device 10 described below to pass through is formed. Between the shielding wall 7B and the shielding wall 7C, a gap large enough to allow the administration device 10 described below to pass through is formed.

[0025] The treatment waiting room 104 is equipped with a movable administration device 10 that administers a radiopharmaceutical to a subject 50. The administration device 10 has a storage section that stores the radiopharmaceutical, a pipe that transports the radiopharmaceutical to the subject 50, a pump that pressure-feeds the radiopharmaceutical, and the like. The administration device 10 moves close to the subject 50 who is the administration target. For example, when the administration device 10 administers a radiopharmaceutical to the subject 50 at the installation section 6A, the administration device 10 moves to the position shown by the imaginary line. At this position, radiation generated from the administration device 10 is shielded by shielding walls 7A and 7D when it is directed toward subjects 50 other than the administration target.

[0026] Next, the actions and effects of the radiopharmaceutical administration equipment 100 according to this embodiment will be described.

[0027] First, as shown in Fig. 1(b), the radiopharmaceutical administration facility according to the comparative example includes a treatment room 105 in which a radiopharmaceutical is administered to a subject 50. Then, in a waiting and recovery room 109 corresponding to the "treatment waiting room 104," only waiting is performed where the subject 50 waits quietly after administration.

[0028] In the radiopharmaceutical administration equipment according to this comparative example, subject 50 is checked in at reception desk 101, and after changing in changing room 102, a medical interview is conducted in examination room 103 for approximately five minutes. Next, a radiopharmaceutical is administered to subject 50 in treatment room 105. Subject 50 then leaves treatment room 105, walks down the hallway, and enters waiting / recovery room 109. Subject 50 waits in waiting / recovery room 109 for approximately 50 minutes. Next, subject 50 urinates in toilet 106. Next, an examination using a PET camera is conducted in examination room 107 for approximately 30 minutes. Next, subject 50 waits in waiting / recovery room 108 for approximately 15 minutes. Finally, subject 50 changes in the changing room and pays at reception desk 101.

[0029] In contrast, the radiopharmaceutical administration equipment 100 according to this embodiment includes a treatment waiting room 104 in which a radiopharmaceutical is administered to the subject 50 and the subject 50 waits for a predetermined time after the administration. The radiopharmaceutical can be administered to the subject 50 in the treatment waiting room 104. Thereafter, the subject 50 can wait for a predetermined time in the same treatment waiting room 104 without moving to another room. In the radiopharmaceutical administration equipment according to the comparative example, the administration was performed for approximately five minutes in the treatment room 105, and the subject 50 moved to the waiting and recovery room 109 and waited for approximately 50 minutes. In contrast, the treatment waiting room 104 allows administration and waiting to occur in the same room. As described above, the movement of the subject 50 after the administration of the radiopharmaceutical can be reduced or eliminated. Furthermore, limiting the movement of the subject 50 after the administration reduces radiation exposure to others.

[0030] The treatment waiting room 104 has a plurality of administration units 2 that perform administration and a plurality of waiting units 3 that perform waiting, and each waiting unit 3 may be associated with a respective administration unit 2. The administration units 2 and waiting units 3 that correspond to each other can be located close to each other or at the same location. In this case, a subject 50 who has been administered a radiopharmaceutical at a certain administration unit 2 can wait by moving a short distance to the corresponding waiting unit 3, or without moving at all.

[0031] The treatment waiting room 104 includes a plurality of installation units 6 for installing the subjects 50, and the administration unit 2 and the waiting unit 3 may be configured by the same installation unit 6. In this case, the subject 50 who has been administered the radiopharmaceutical in the administration unit 2 may wait there without moving.

[0032] The treatment waiting room 104 may include a plurality of installation sections 6 in which subjects 50 are placed, and shielding walls 7 for blocking radiation may be provided between the installation sections 6. In this case, when a radiopharmaceutical is being administered to the subject 50 placed in installation section 6A, the shielding wall 7A can block radiation directed toward the subject 50 placed in the adjacent installation section 6B.

[0033] The radiopharmaceutical administration equipment 100 may further include a movable administration device 10 that administers a radiopharmaceutical to the subject 50. In this case, the administration device 10 is movable and can be moved close to each subject 50. Therefore, the radiopharmaceutical can be administered to the subject 50 at each administration unit 2 without the subject 50 having to move.

[0034] The treatment waiting room 104 has a plurality of administration units 2 for administration, and the floor surface 104a between the administration units 2 does not need to have any steps. In this case, the administration device 10 can move smoothly on the floor surface 104a and move close to each administration unit 2.

[0035] Furthermore, since the treatment room 105 of the comparative example can be omitted, the building footprint can be reduced. Furthermore, by making the treatment waiting room 104 larger, the number of subjects 50 can be increased. Furthermore, since the worker (caregiver) does not have to guide the subject 50 from the treatment room 105 to the waiting and recovery room 109, the burden on the worker can be reduced.

[0036] The present invention is not limited to the above-described embodiments.

[0037] For example, a radiopharmaceutical administration equipment 100 shown in Fig. 3 may be employed. The radiopharmaceutical administration equipment 100 shown in Fig. 3 is provided next to the treatment waiting room 104 and further includes an administration equipment room 120 in which administration equipment 121 that supplies a radiopharmaceutical is placed. The administration equipment room 120 supplies the radiopharmaceutical to the administration unit 2 that performs administration in the treatment waiting room 104 via a transport flow path 130 that transports the radiopharmaceutical.

[0038] The administration equipment room 120 is a compartment separated by wall 110, wall 112, wall 111, and wall 116. The administration equipment room 120 is separated by the portions of wall 110, 111 that extend further toward the negative side in the X-axis direction than wall 112. Wall 116 faces wall 112 in parallel at a position spaced apart from wall 112 toward the negative side in the X-axis direction. The administration equipment 121 pressure-feeds the radiopharmaceutical to each administration unit 2 in the treatment waiting room 104 via the transport flow path 130.

[0039] Transport flow path 130 includes common flow path 131, administration flow paths 132A, 132B, 132C, 132D, and 132E, and supply flow path 133. Common flow path 131 is a pipe extending along each of wall portions 112, 111, and 113. Supply flow path 133 is a pipe that supplies a radiopharmaceutical from administration equipment 121 to common flow path 131. Administration flow paths 132A, 132B, 132C, 132D, and 132E are pipes that branch off from common flow path 131 and administer a radiopharmaceutical to subject 50 installed in installation units 6A, 6B, 6C, 6D, and 6E. Administration flow path 132A is drawn out from a position of common flow path 131 arranged on wall portion 112 that corresponds to installation unit 6A in the Y-axis direction toward the positive side in the X-axis direction. Similarly, the other administration channels 132A are drawn out from the wall portions close to the installation portions 6B, 6C, 6D, and 6E.

[0040] As described above, a radiopharmaceutical can be supplied from administration equipment room 120 to subject 50 at each of installation sections 6A, 6B, 6C, 6D, 6E, and 6E (administration section 2) via transport flow path 130. Therefore, the radiopharmaceutical can be administered to subject 50 at each of installation sections 6A, 6B, 6C, 6D, 6E, and 6E (administration section 2) without subject 50 having to move.

[0041] Here, transport channel 130 from administration equipment room 120 may pass through grooves 140 or through-holes 150 (see FIG. 4 ) provided in the walls separating each room, and may be extended to each of installation sections 6A, 6B, 6C, 6D, 6E, 6E (administration section 2). In this case, the wall sections can extend transport channel 130 to each of installation sections 6A, 6B, 6C, 6D, 6E, 6E (administration section 2) while shielding radiation from transport channel 130 that transports the radiopharmaceutical.

[0042] For example, the structure shown in Fig. 4(a) may be adopted. As shown in Fig. 4(a), a groove 140 is formed in the upper end of the wall 112. A further groove 141 is formed in the groove 140. The transport flow path 130 (common flow path 131) is disposed within the groove 141. The groove 141 is closed by a shielding material 142 for piping shielding. As a result, radiation from the radiopharmaceutical flowing through the transport flow path 130 within the groove 141 is shielded by the wall 112 and the shielding material 142.

[0043] 4(b) may also be employed. As shown in FIG. 4(b), a through-hole 150 is formed near the upper end of the wall 112. A groove 141 is further formed in the through-hole 150. The transport flow path 130 (common flow path 131) is disposed within the groove 141. The groove 141 is closed by a shielding material 142 for piping shielding. As a result, radiation from the radiopharmaceutical flowing through the transport flow path 130 within the groove 141 is shielded by the wall 112 and the shielding material 142.

[0044] The transport channel 130 from the administration equipment room 120 may extend to the administration section not only through the walls but also through a groove or through-hole provided in at least one selected from the walls, floor, and ceiling that separate each room. For example, a piping pit may be dug in the center of the room and shielded with lead plates, or the piping may be embedded in the ceiling and shielded with lead plates. The piping may also run from the wall to the floor or from the wall to the ceiling.

[0045] Also, a radiopharmaceutical administration system 100 shown in Fig. 5 may be employed. In Fig. 4, drugs are distributed to each of the installation sections 6A, 6B, 6C, 6D, 6E, and 6E via administration flow paths 132A, 132B, 132C, 132D, and 132E branching from a common flow path 131. The radiopharmaceutical administration system 100 shown in Fig. 5 distributes drugs from administration equipment 121 to each of the installation sections 6A, 6B, 6C, 6D, 6E, and 6E via transport flow paths 160A, 160B, 160C, 160D, and 160E, which are configured as independent single pipes. In this case, drugs can be simultaneously administered to subjects 50 at each of the installation sections 6A, 6B, 6C, 6D, 6E, and 6E.

[0046] Also, a radiopharmaceutical administration equipment 100 shown in FIG. 6 may be employed. Unlike the radiopharmaceutical administration equipment 100 shown in FIG. 2, the radiopharmaceutical administration equipment 100 shown in FIG. 6 has an L-shaped shielding wall. Specifically, shielding walls 7A, 7B, and 7C have a bent portion 7a that bends from their tip in the X-axis direction toward the Y-axis direction. Furthermore, shielding walls 7D and 7E that extend from wall portion 111 toward the positive side in the Y-axis direction are provided for installation units 6A and 6E. In this case, administration device 10 is placed next to installation unit 6A, and operator 51 retreats to the opposite side across shielding wall 7D, and can remotely operate administration device 10 from that position.

[0047] As shown in Fig. 7, the shielding wall 7A may have a through-hole 54 through which a tube 55 for transporting a radiopharmaceutical passes. In this case, when administering a radiopharmaceutical to a subject 50 from the administration device 10, the administration device 10 is placed on the opposite side of the shielding wall 7A, and the radiopharmaceutical can be administered to the subject 50 through the tube 55 passing through the through-hole 54 in the shielding wall 7A. In this case, an operator 51 operating the administration device 10 can administer the radiopharmaceutical to the subject 50 with the shielding wall 7A in between. [Explanation of symbols]

[0048] 2...administration section, 3...waiting section, 6...installation section, 7...shielding wall, 10...administration device, 100...radioactive drug administration device, 104...treatment waiting room, 120...administration equipment room, 121...administration equipment, 130, 160...transport flow path, 140...groove section, 150...through hole.

Claims

1. A radiopharmaceutical administration device for administering a radiopharmaceutical to a subject, a treatment waiting room in which the radiopharmaceutical is administered to the subject and the subject waits for a predetermined time after the administration of the radiopharmaceutical; The radioactive drug administration equipment is configured to supply the radioactive drug from an administration equipment room to an administration unit that performs the administration in the treatment waiting room via a transport flow path that passes through a shielding wall.

2. The treatment waiting room has a plurality of administration units that perform the administration and a plurality of waiting units that perform the waiting, 2. The radiopharmaceutical administration equipment according to claim 1, wherein each of the standby units is associated with each of the administration units.

3. The treatment waiting room includes a plurality of installation units for installing the subject, The radiopharmaceutical administration equipment according to claim 2 , wherein the administration section and the standby section are configured by the same installation section.

4. The treatment waiting room includes a plurality of installation units for installing the subject, 4. The radiopharmaceutical administration equipment according to claim 1, wherein a shielding wall for blocking radiation is provided between the installation sections.

5. A radiopharmaceutical administration device for administering a radiopharmaceutical to a subject, comprising: a treatment waiting room in which the radiopharmaceutical is administered to the subject and the subject waits for a predetermined time after the administration of the radiopharmaceutical; The treatment waiting room includes a plurality of installation units for installing the subject, a shielding wall that blocks radiation is provided between the installation portions, A radiopharmaceutical administration facility, wherein the shielding wall has a through-hole through which a tube for transporting the radiopharmaceutical passes.

6. A radiopharmaceutical administration device for administering a radiopharmaceutical to a subject, comprising: a treatment waiting room in which the radiopharmaceutical is administered to the subject and the subject waits for a predetermined time after the administration of the radiopharmaceutical; an administration equipment room provided adjacent to the treatment waiting room and in which administration equipment for supplying the radiopharmaceutical is placed; The administration equipment room supplies the radioactive drug to an administration section that performs the administration in the treatment waiting room via a transport flow path.

7. 7. The radiopharmaceutical administration equipment of claim 6, wherein the transport flow path from the administration equipment room extends to the administration section by passing through a groove or a penetration provided in at least one selected from the walls, floor, and ceiling separating each room.

8. A radiopharmaceutical administration device for administering a radiopharmaceutical to a subject, comprising: a treatment waiting room in which the radiopharmaceutical is administered to the subject and the subject waits for a predetermined time after the administration of the radiopharmaceutical; The treatment waiting room has a plurality of installation units for installing the subject, A radiopharmaceutical administration equipment in which the radiopharmaceuticals shared by the plurality of installation units are supplied from a single administration equipment room via a transport flow path having at least a portion of a common route.

9. A radiopharmaceutical administration device for administering a radiopharmaceutical to a subject, comprising: a treatment waiting room in which the radiopharmaceutical is administered to the subject and the subject waits for a predetermined time after the administration of the radiopharmaceutical; A radioactive drug administration facility in which a transport flow path passing through a groove or through-hole provided in at least one selected from the walls, floor, and ceiling separating each room is extended to an administration section in the treatment waiting room where the administration is performed.

Images